{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:18:02Z","timestamp":1793452682350,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136418"],"award-info":[{"award-number":["1136418"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1146128"],"award-info":[{"award-number":["1146128"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1159261"],"award-info":[{"award-number":["1159261"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012308","name":"National Jewish Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.preghy.2022.07.005","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T12:48:17Z","timestamp":1659012497000},"page":"13-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors"],"prefix":"10.1016","volume":"30","author":[{"given":"Natasha","family":"de Alwis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie K.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu'uhevaha J.","family":"Kaitu'u-Lino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.preghy.2022.07.005_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstetrics Gynecol. Reprod. Biol."},{"key":"10.1016\/j.preghy.2022.07.005_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2022.07.005_b0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbamcr.2010.01.014","article-title":"Fifteen formins for an actin filament: a molecular view on the regulation of human formins","volume":"1803","author":"Sch\u00f6nichen","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.005_b0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.devcel.2011.10.025","article-title":"Daam2 is required for dorsal patterning via modulation of canonical Wnt signaling in the developing spinal cord","volume":"22","author":"Lee Hyun","year":"2012","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.preghy.2022.07.005_b0025","doi-asserted-by":"crossref","first-page":"e0232025","DOI":"10.1371\/journal.pone.0232025","article-title":"Placental defects lead to embryonic lethality in mice lacking the Formin and PCP proteins Daam1 and Daam2","volume":"15","author":"Nakaya","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.preghy.2022.07.005_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-020-01605-x","article-title":"Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth","volume":"18","author":"Hannan","year":"2020","journal-title":"BMC Medicine."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.005_b0035","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41598-021-84785-7","article-title":"DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia","volume":"11","author":"de Alwis","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.preghy.2022.07.005_b0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.preghy.2022.07.005_b0045","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy: executive summary","volume":"122","author":"Roberts","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.07.005_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.placenta.2013.11.005","article-title":"Optimising sample collection for placental research","volume":"35","author":"Burton","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.preghy.2022.07.005_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.preghy.2014.09.003","article-title":"Original Article: Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin","volume":"4","author":"Kaitu\u2019u-Lino","year":"2014","journal-title":"Pregnancy Hypertension"},{"issue":"7","key":"10.1016\/j.preghy.2022.07.005_b0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating Angiogenic Factors and the Risk of Preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.preghy.2022.07.005_b0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.preghy.2022.07.005_b0070","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"7","key":"10.1016\/j.preghy.2022.07.005_b0075","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1210\/jc.2009-0017","article-title":"A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia","volume":"94","author":"Thomas","year":"2009","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"1","key":"10.1016\/j.preghy.2022.07.005_b0080","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/s41467-020-16346-x","article-title":"Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction","volume":"11","author":"Kaitu\u2019u-Lino","year":"2020","journal-title":"Nature Commun."},{"issue":"4","key":"10.1016\/j.preghy.2022.07.005_b0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3390\/jcm11040901","article-title":"Circulating SPINT1 is reduced in a preeclamptic cohort with co-existing fetal growth restriction","volume":"11","author":"Murphy","year":"2022","journal-title":"J. Clin. Med."},{"issue":"22","key":"10.1016\/j.preghy.2022.07.005_b0090","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1002689","article-title":"Use of proton-pump inhibitors in early pregnancy and the risk of birth defects","volume":"363","author":"Pasternak","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.preghy.2022.07.005_b0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10620-011-1940-3","article-title":"The safety of fetal exposure to proton-pump inhibitors during pregnancy","volume":"57","author":"Matok","year":"2012","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.preghy.2022.07.005_b0100","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ajg.2009.122","article-title":"The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis","volume":"104","author":"Gill","year":"2009","journal-title":"Official J. Am. College Gastroenterol. | ACG"},{"key":"10.1016\/j.preghy.2022.07.005_b0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.preghy.2020.07.013","article-title":"Esomeprazole and sulfasalazine in combination additively reduce sFlt-1 secretion and diminish endothelial dysfunction: potential for a combination treatment for preeclampsia","volume":"22","author":"Binder","year":"2020","journal-title":"Pregnancy Hypertension"},{"issue":"3","key":"10.1016\/j.preghy.2022.07.005_b0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.118.12300","article-title":"EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion","volume":"73","author":"Hastie","year":"2019","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.preghy.2022.07.005_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147407","article-title":"Megalin, proton pump inhibitors and the renin-angiotensin system in healthy and pre-eclamptic placentas","volume":"22","author":"Sun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.preghy.2022.07.005_b0120","article-title":"Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia","volume":"13","author":"Kaitu'u-Lino","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.preghy.2022.07.005_b0125","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","article-title":"Low soluble Fms-like tyrosine kinase-1, endoglin, and endothelin-1 levels in women with confirmed or suspected preeclampsia using proton pump inhibitors","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.preghy.2022.07.005_b0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008211","article-title":"Double blind, randomised, placebo-controlled trial to evaluate the efficacy of esomeprazole to treat early onset pre-eclampsia (PIE Trial): a study protocol","volume":"5","author":"Cluver","year":"2015","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.preghy.2022.07.005_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.07.019","article-title":"Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial","volume":"219","author":"Cluver","year":"2018","journal-title":"Am. J. Obstetrics Gynecol."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077892200071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077892200071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:57:40Z","timestamp":1761897460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221077892200071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"alternative-id":["S221077892200071X"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2022.07.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2022.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}